XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Revenues | 3 Months Ended
--- | ---
Mar. 31, 2025
Revenue from Contract with Customer [Abstract] |
Revenues | Revenues The following table presents a summary of total revenues (in thousands):
|  |  | Three Months Ended March 31, |  |  |  |
|  |  |  |  | 2025 |  | 2024 |  |  |  |
Xywav |  |  |  |  | $ | 344,804 |  |  | $ | 315,300 |  |  |  |  |
Xyrem |  |  |  |  | 37,241 |  |  | 64,232 |  |  |  |  |
Epidiolex/Epidyolex |  |  |  |  | 217,737 |  |  | 198,716 |  |  |  |  |
Sativex |  |  |  |  | 5,407 |  |  | 2,735 |  |  |  |  |
Total Neuroscience |  |  |  |  | 605,189 |  |  | 580,983 |  |  |  |  |
Rylaze/Enrylaze |  |  |  |  | 94,233 |  |  | 102,750 |  |  |  |  |
Zepzelca |  |  |  |  | 63,033 |  |  | 75,100 |  |  |  |  |
Defitelio/defibrotide |  |  |  |  | 40,662 |  |  | 47,676 |  |  |  |  |
Vyxeos |  |  |  |  | 29,544 |  |  | 32,023 |  |  |  |  |
Ziihera |  |  |  |  | 1,975 |  |  | — |  |  |  |  |
Total Oncology |  |  |  |  | 229,447 |  |  | 257,549 |  |  |  |  |
Other |  |  |  |  | 4,782 |  |  | 3,570 |  |  |  |  |
Product sales, net |  |  |  |  | 839,418 |  |  | 842,102 |  |  |  |  |
High-sodium oxybate AG royalty revenue |  |  |  |  | 48,946 |  |  | 49,947 |  |  |  |  |
Other royalty and contract revenues |  |  |  |  | 9,477 |  |  | 9,934 |  |  |  |  |
Total revenues |  |  |  |  | $ | 897,841 |  |  | $ | 901,983 |  |  |  |  |
The following table presents a summary of total revenues attributed to geographic sources (in thousands):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2025 |  | 2024
United States |  |  |  |  | $ | 797,945 |  |  | $ | 808,214 |
Europe |  |  |  |  | 83,607 |  |  | 71,355 |
All other |  |  |  |  | 16,289 |  |  | 22,414 |
Total revenues |  |  |  |  | $ | 897,841 |  |  | $ | 901,983 |
The following table presents a summary of the percentage of total revenues from customers that represented more than 10% of our total revenues:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2025 |  | 2024
ESSDS |  |  |  |  | 42 | % |  | 42 | %
ASD |  |  |  |  | 12 | % |  | 6 | %
McKesson |  |  |  |  | 11 | % |  | 12 | %
Financing and payment Our payment terms vary by the type and location of our customer but payment is generally required in a term ranging from 30 to 65 days.

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 606 -Publisher FASB -URI https://asc.fasb.org/606/tableOfContent + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration